Patent · US Active

Single-molecule sequence and high sensitivity methylation analysis for tissue-specific analysis

US11920201B2 · kind B2 · utility

0Cited by

1References

24Claims

0Family size

Assignee

Siemens Healthcare Limited · DE

Inventors

Carsten Dietrich · Nuremberg, DE
Andreas Posch · Wien, AT

Key dates

Filing date	Jan 23, 2018
Grant date	Mar 5, 2024
Priority date	—
Expiry date	Jul 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided herein are methods of determining one or more modification(s) of the nucleic acid sequence of at least one nucleic acid and at least one epigenetic alteration of the at least one nucleic acid in a sample of a subject. The sample is derived from a body fluid of the subject. The methods link the one or more modification(s) to a specific cell type.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.